These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33388023)

  • 41. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.
    Chien HY; Chen CY; Chiu YH; Lin YC; Li WC
    Int J Med Sci; 2016; 13(6):457-65. PubMed ID: 27279796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. microRNA Expression Profiling Based on Microarray Approach in Human Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
    Zhou H; Peng C; Huang DS; Liu L; Guan P
    DNA Cell Biol; 2020 Mar; 39(3):441-450. PubMed ID: 32101049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1.
    Liu HN; Cao NJ; Li X; Qian W; Chen XL
    Biochem Biophys Res Commun; 2018 Nov; 505(4):1236-1243. PubMed ID: 30333091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy.
    Liang Z; Gao KP; Wang YX; Liu ZC; Tian L; Yang XZ; Ding JY; Wu WT; Yang WH; Li YL; Zhang ZB; Zhai RH
    Am J Physiol Endocrinol Metab; 2018 Sep; 315(3):E374-E385. PubMed ID: 29812988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miRNA-1273g-3p Involvement in Development of Diabetic Retinopathy by Modulating the Autophagy-Lysosome Pathway.
    Ye Z; Li ZH; He SZ
    Med Sci Monit; 2017 Dec; 23():5744-5751. PubMed ID: 29197896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulated VEGF and Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy.
    Gong Q; Li F; Xie J; Su G
    Endocrine; 2019 Jul; 65(1):35-45. PubMed ID: 30980286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum miR-122 levels correlate with diabetic retinopathy.
    Pastukh N; Meerson A; Kalish D; Jabaly H; Blum A
    Clin Exp Med; 2019 May; 19(2):255-260. PubMed ID: 30673918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of microRNA-133b on retinal vascular endothelial cell proliferation and apoptosis through angiotensinogen-mediated angiotensin II- extracellular signal-regulated kinase 1/2 signalling pathway in rats with diabetic retinopathy.
    Liu TT; Hao Q; Zhang Y; Li ZH; Cui ZH; Yang W
    Acta Ophthalmol; 2018 Aug; 96(5):e626-e635. PubMed ID: 29488353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced ROBO4 is mediated by up-regulation of HIF-1α/SP1 or reduction in miR-125b-5p/miR-146a-5p in diabetic retinopathy.
    Gong Q; Xie J; Li Y; Liu Y; Su G
    J Cell Mol Med; 2019 Jul; 23(7):4723-4737. PubMed ID: 31094072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
    Wang L; Liu WX; Huang XG
    Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The potential role of m6A RNA methylation in diabetic retinopathy.
    Kumari N; Karmakar A; Ahamad Khan MM; Ganesan SK
    Exp Eye Res; 2021 Jul; 208():108616. PubMed ID: 33979630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects.
    Mazzeo A; Beltramo E; Lopatina T; Gai C; Trento M; Porta M
    Exp Eye Res; 2018 Nov; 176():69-77. PubMed ID: 30008390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic Mechanisms in Type 2 Diabetes Retinopathy: A Systematic Review.
    Milluzzo A; Maugeri A; Barchitta M; Sciacca L; Agodi A
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiogenic microRNAs Linked to Incidence and Progression of Diabetic Retinopathy in Type 1 Diabetes.
    Zampetaki A; Willeit P; Burr S; Yin X; Langley SR; Kiechl S; Klein R; Rossing P; Chaturvedi N; Mayr M
    Diabetes; 2016 Jan; 65(1):216-27. PubMed ID: 26395742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dysregulation of miR-210 is involved in the development of diabetic retinopathy and serves a regulatory role in retinal vascular endothelial cell proliferation.
    Yin C; Lin X; Sun Y; Ji X
    Eur J Med Res; 2020 May; 25(1):20. PubMed ID: 32498701
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathogenic Role of
    Chen Q; Qiu F; Zhou K; Matlock HG; Takahashi Y; Rajala RVS; Yang Y; Moran E; Ma JX
    Diabetes; 2017 Jun; 66(6):1671-1682. PubMed ID: 28270521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-200c-3p regulates pyroptosis by targeting SLC30A7 in diabetic retinopathy.
    Li W; Yang S; Chen G; He S
    Hum Exp Toxicol; 2022; 41():9603271221099589. PubMed ID: 35607288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-135b-5p promotes endothelial cell proliferation and angiogenesis in diabetic retinopathy mice by inhibiting Von Hipp-el-Lindau and elevating hypoxia inducible factor α expression.
    Liu L; Xu H; Zhao H; Sui D
    J Drug Target; 2021 Mar; 29(3):300-309. PubMed ID: 33032456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppressing long noncoding RNA OGRU ameliorates diabetic retinopathy by inhibition of oxidative stress and inflammation via miR-320/USP14 axis.
    Fu S; Zheng Y; Sun Y; Lai M; Qiu J; Gui F; Zeng Q; Liu F
    Free Radic Biol Med; 2021 Jun; 169():361-381. PubMed ID: 33762162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats.
    Kovacs B; Lumayag S; Cowan C; Xu S
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4402-9. PubMed ID: 21498619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.